Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from SBFM

How job creation is driven by business growth and investing in job retention

Colin Shute, Group CEO and Founder of SBFM, shares his thoughts on being included in the E2E Job Creation 100 list

The Independent UK

The E2E Job Creation 100 track 2024

The E2E Job Creation 100 track 2024

Meet the top 100 business leaders creating jobs in the UK economy

The Independent UK

The job vacancies in Greater Manchester you can apply for now that don’t require any qualifications

The job vacancies in Greater Manchester you can apply for now that don’t require any qualifications

There are a variety of exciting roles on offer across the region

Manchester Evening News

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

SBFM: Working to Change the Cancer Fight

By Brad Sorensen, CFA NASDAQ:SBFM

EXCLUSIVE: Sunshine Biopharma Looks Ahead In COVID And Cancer Treatments

Sunshine Biopharma Inc. (NASDAQ: SBFM) might be living the concept of being in the right place at the right time.

Does Sunshine Biopharma Deserve a Place in Your Portfolio?

Today I'll analyze Sunshine Biopharma (SBFM), which is up more than 100% in the past month, to determine if it deserves a place in your portfolio.

What's Going On With Sunshine Biopharma Stock Today?

Sunshine Biopharma Inc (NASDAQ: SBFM) is trading higher Wednesday on continued momentum after the company on Tuesday announced that two of its designed mRNA molecules are effective at destroying cancer cells grown in culture.

inkl

Read news from The Economist, FT, and more,
with one subscription

EXCLUSIVE: Sunshine Biopharma's Newly Designed mRNA Molecules Effective Against Multidrug Resistant Cancer Cells

EXCLUSIVE: Sunshine Biopharma's Newly Designed mRNA Molecules Effective Against Multidrug Resistant Cancer Cells

Oncology and antiviral drugs focused Sunshine Biopharma Inc (NASDAQ: SBFM) has said that two of its newly designed mRNA molecules can effectively destroy cancer cells grown in culture.

87 Biggest Movers From Yesterday

87 Biggest Movers From Yesterday

Gainers Sunshine Biopharma, Inc. (NASDAQ: SBFM) shares jumped 150% to close at $3.80 on Wednesday. Sunshine Biopharma, last month, priced its 1.88 million unit uplisting to Nasdaq at $4.25 per unit.

People

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

Bright Horizons

Sunshine Biopharma

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

117,781 stories

Greater Manchester

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play